| cellular amino acid metabolic process | GO:0006520 | 103 | 0.256 | |
| axonogenesis | GO:0007409 | 274 | 0.171 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.149 | |
| regionalization | GO:0003002 | 337 | 0.145 | |
| ossification | GO:0001503 | 216 | 0.135 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.133 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.119 | |
| epidermis development | GO:0008544 | 187 | 0.114 | |
| cell adhesion | GO:0007155 | 329 | 0.113 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.111 | |
| connective tissue development | GO:0061448 | 179 | 0.107 | |
| amine metabolic process | GO:0009308 | 45 | 0.106 | |
| embryonic placenta development | GO:0001892 | 98 | 0.105 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.100 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.100 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.099 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.099 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.096 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.092 | |
| skin development | GO:0043588 | 220 | 0.091 | |
| dna metabolic process | GO:0006259 | 303 | 0.090 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.090 | |
| muscle tissue development | GO:0060537 | 308 | 0.089 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.088 | |
| wound healing | GO:0042060 | 157 | 0.085 | |
| cell fate commitment | GO:0045165 | 210 | 0.085 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.083 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.083 | |
| skeletal system development | GO:0001501 | 356 | 0.082 | |
| t cell differentiation | GO:0030217 | 174 | 0.082 | |
| developmental maturation | GO:0021700 | 193 | 0.082 | |
| cellular homeostasis | GO:0019725 | 240 | 0.080 | |
| spermatogenesis | GO:0007283 | 284 | 0.079 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.078 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.077 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.077 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.077 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.075 | |
| paraxial mesodermal cell fate commitment | GO:0048343 | 2 | 0.074 | |
| ear morphogenesis | GO:0042471 | 118 | 0.073 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.072 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.072 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.069 | |
| cellular response to glucose stimulus | GO:0071333 | 45 | 0.069 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.069 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.068 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.066 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.066 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.066 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.065 | |
| hindbrain development | GO:0030902 | 128 | 0.065 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.065 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.064 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.064 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.064 | |
| blood circulation | GO:0008015 | 195 | 0.063 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.063 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.062 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.061 | |
| t cell activation | GO:0042110 | 289 | 0.060 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.060 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.060 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.058 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.058 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.058 | |
| glucose homeostasis | GO:0042593 | 128 | 0.058 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.058 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.057 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.057 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.057 | |
| cartilage development | GO:0051216 | 140 | 0.056 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.056 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.056 | |
| male gamete generation | GO:0048232 | 285 | 0.056 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.055 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.055 | |
| regulation of cell motility | GO:2000145 | 236 | 0.054 | |
| placenta development | GO:0001890 | 140 | 0.054 | |
| molting cycle | GO:0042303 | 90 | 0.053 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.053 | |
| gland development | GO:0048732 | 330 | 0.053 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.053 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.053 | |
| respiratory tube development | GO:0030323 | 167 | 0.052 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.052 | |
| hair follicle development | GO:0001942 | 85 | 0.052 | |
| ventricular cardiac muscle cell action potential | GO:0086005 | 4 | 0.051 | |
| cellular response to carbohydrate stimulus | GO:0071322 | 50 | 0.051 | |
| respiratory system development | GO:0060541 | 190 | 0.051 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.051 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.051 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.051 | |
| neuron migration | GO:0001764 | 122 | 0.051 | |
| neuron projection guidance | GO:0097485 | 141 | 0.051 | |
| stem cell proliferation | GO:0072089 | 117 | 0.050 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.050 | |
| positive regulation of macroautophagy | GO:0016239 | 3 | 0.050 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.050 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.050 | |
| chemotaxis | GO:0006935 | 247 | 0.049 | |
| response to monosaccharide | GO:0034284 | 67 | 0.049 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.049 | |
| primary neural tube formation | GO:0014020 | 95 | 0.049 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.048 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.048 | |
| cellular glucose homeostasis | GO:0001678 | 52 | 0.048 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.048 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.048 | |
| cytokine production | GO:0001816 | 319 | 0.048 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.047 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.047 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.047 | |
| cell growth | GO:0016049 | 130 | 0.047 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.047 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.046 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.046 | |
| non canonical wnt signaling pathway involved in heart development | GO:0061341 | 3 | 0.046 | |
| epithelial cell migration | GO:0010631 | 63 | 0.046 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.046 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.046 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.046 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.046 | |
| prostate gland stromal morphogenesis | GO:0060741 | 2 | 0.046 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.046 | |
| epithelium migration | GO:0090132 | 63 | 0.046 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.045 | |
| gonad development | GO:0008406 | 141 | 0.045 | |
| locomotory behavior | GO:0007626 | 195 | 0.045 | |
| hair cycle | GO:0042633 | 90 | 0.045 | |
| axon guidance | GO:0007411 | 141 | 0.045 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.045 | |
| gtp catabolic process | GO:0006184 | 143 | 0.045 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.045 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.044 | |
| camera type eye development | GO:0043010 | 266 | 0.044 | |
| female sex determination | GO:0030237 | 1 | 0.044 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.044 | |
| somatic sex determination | GO:0018993 | 2 | 0.043 | |
| regulation of neuroblast proliferation | GO:1902692 | 27 | 0.043 | |
| nephron epithelium development | GO:0072009 | 92 | 0.043 | |
| steroid metabolic process | GO:0008202 | 119 | 0.043 | |
| insulin secretion | GO:0030073 | 89 | 0.043 | |
| circulatory system process | GO:0003013 | 197 | 0.042 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.042 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.042 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.042 | |
| neural tube development | GO:0021915 | 160 | 0.042 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.041 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.041 | |
| forebrain development | GO:0030900 | 302 | 0.041 | |
| stem cell development | GO:0048864 | 219 | 0.040 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.040 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.040 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.040 | |
| negative regulation of growth | GO:0045926 | 99 | 0.040 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.040 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.039 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.039 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.039 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.039 | |
| carbon catabolite activation of transcription | GO:0045991 | 4 | 0.039 | |
| sensory perception | GO:0007600 | 245 | 0.038 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.038 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.038 | |
| microtubule based process | GO:0007017 | 236 | 0.038 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.038 | |
| regulation of transcription from rna polymerase iii promoter | GO:0006359 | 2 | 0.038 | |
| cell cell adhesion | GO:0098609 | 41 | 0.038 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.038 | |
| transmembrane transport | GO:0055085 | 412 | 0.038 | |
| stem cell differentiation | GO:0048863 | 268 | 0.038 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.038 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.037 | |
| oxidation reduction process | GO:0055114 | 342 | 0.037 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.037 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.037 | |
| regulation of cell growth | GO:0001558 | 91 | 0.037 | |
| regulation of cell migration | GO:0030334 | 219 | 0.037 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.037 | |
| negative regulation of dendritic spine morphogenesis | GO:0061002 | 3 | 0.037 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.037 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.036 | |
| segmentation | GO:0035282 | 93 | 0.036 | |
| regulation of cell activation | GO:0050865 | 289 | 0.036 | |
| glomerular mesangial cell differentiation | GO:0072008 | 3 | 0.036 | |
| metencephalon development | GO:0022037 | 89 | 0.036 | |
| dna endoreduplication | GO:0042023 | 4 | 0.036 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.036 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.035 | |
| skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration | GO:0014834 | 3 | 0.035 | |
| hemostasis | GO:0007599 | 78 | 0.035 | |
| positive regulation of epithelial cell proliferation involved in lung morphogenesis | GO:0060501 | 3 | 0.035 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.035 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.035 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.034 | |
| heart morphogenesis | GO:0003007 | 178 | 0.034 | |
| neural tube closure | GO:0001843 | 90 | 0.034 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.034 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.034 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.034 | |
| regulation of secretion | GO:0051046 | 274 | 0.033 | |
| peptide transport | GO:0015833 | 133 | 0.033 | |
| ear development | GO:0043583 | 200 | 0.033 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.033 | |
| cellular response to monosaccharide stimulus | GO:0071326 | 47 | 0.033 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.033 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.033 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.033 | |
| neural tube patterning | GO:0021532 | 43 | 0.033 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.032 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.032 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.032 | |
| epithelial to mesenchymal transition | GO:0001837 | 47 | 0.032 | |
| appendage development | GO:0048736 | 166 | 0.032 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.032 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.032 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.032 | |
| organelle localization | GO:0051640 | 179 | 0.032 | |
| negative regulation of cell morphogenesis involved in differentiation | GO:0010771 | 48 | 0.032 | |
| epithelial cell development | GO:0002064 | 159 | 0.031 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.031 | |
| regulation of ion transport | GO:0043269 | 215 | 0.031 | |
| epithelial tube formation | GO:0072175 | 130 | 0.031 | |
| cellular response to hexose stimulus | GO:0071331 | 47 | 0.031 | |
| response to acid chemical | GO:0001101 | 111 | 0.031 | |
| glucose metabolic process | GO:0006006 | 92 | 0.031 | |
| extracellular structure organization | GO:0043062 | 148 | 0.031 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.031 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.031 | |
| renal capsule morphogenesis | GO:0072128 | 1 | 0.031 | |
| mesoderm formation | GO:0001707 | 62 | 0.031 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.031 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.031 | |
| mesonephros development | GO:0001823 | 97 | 0.031 | |
| renal system development | GO:0072001 | 225 | 0.031 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.030 | |
| regulation of embryonic development | GO:0045995 | 71 | 0.030 | |
| detection of stimulus | GO:0051606 | 84 | 0.030 | |
| kidney epithelium development | GO:0072073 | 121 | 0.030 | |
| amide transport | GO:0042886 | 138 | 0.030 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.030 | |
| granulosa cell differentiation | GO:0060014 | 1 | 0.030 | |
| epithelial mesenchymal signaling involved in prostate gland development | GO:0060738 | 2 | 0.030 | |
| synaptic transmission | GO:0007268 | 329 | 0.030 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.030 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.030 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.030 | |
| renal vesicle induction | GO:0072034 | 3 | 0.030 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.030 | |
| negative regulation of glucokinase activity | GO:0033132 | 4 | 0.030 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.029 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.029 | |
| nephron tubule development | GO:0072080 | 84 | 0.029 | |
| kidney development | GO:0001822 | 213 | 0.029 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.029 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.029 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.029 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.029 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.029 | |
| planar cell polarity pathway involved in ventricular septum morphogenesis | GO:0061348 | 2 | 0.029 | |
| tissue migration | GO:0090130 | 68 | 0.029 | |
| positive regulation of transcription from rna polymerase ii promoter by glucose | GO:0000432 | 3 | 0.029 | |
| protein localization to organelle | GO:0033365 | 185 | 0.029 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.029 | |
| neural crest cell differentiation | GO:0014033 | 54 | 0.029 | |
| hexose metabolic process | GO:0019318 | 98 | 0.028 | |
| secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | GO:0060528 | 4 | 0.028 | |
| progesterone secretion | GO:0042701 | 1 | 0.028 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.028 | |
| mesangial cell differentiation | GO:0072007 | 4 | 0.028 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.028 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.028 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.028 | |
| regulation of ossification | GO:0030278 | 112 | 0.028 | |
| positive regulation of transcription by glucose | GO:0046016 | 3 | 0.028 | |
| renal tubule development | GO:0061326 | 87 | 0.028 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.028 | |
| transcription from rna polymerase iii promoter | GO:0006383 | 3 | 0.028 | |
| b cell activation | GO:0042113 | 161 | 0.028 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.028 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.028 | |
| digestive system development | GO:0055123 | 200 | 0.028 | |
| pallium development | GO:0021543 | 120 | 0.028 | |
| muscular septum morphogenesis | GO:0003150 | 4 | 0.028 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.028 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.028 | |
| outflow tract morphogenesis | GO:0003151 | 53 | 0.028 | |
| notch signaling pathway | GO:0007219 | 71 | 0.028 | |
| regulation of epithelial cell migration | GO:0010632 | 35 | 0.027 | |
| positive regulation of transcription from rna polymerase iii promoter | GO:0045945 | 1 | 0.027 | |
| pancreas development | GO:0031016 | 57 | 0.027 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.027 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.027 | |
| labyrinthine layer blood vessel development | GO:0060716 | 21 | 0.027 | |
| regulation of vascular wound healing | GO:0061043 | 2 | 0.027 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.027 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.027 | |
| endocrine pancreas development | GO:0031018 | 29 | 0.027 | |
| adult behavior | GO:0030534 | 135 | 0.027 | |
| negative regulation of dendritic spine development | GO:0061000 | 3 | 0.027 | |
| negative regulation of wnt signaling pathway involved in heart development | GO:0003308 | 4 | 0.026 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.026 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.026 | |
| positive regulation of neuroblast proliferation | GO:0002052 | 19 | 0.026 | |
| lung development | GO:0030324 | 164 | 0.026 | |
| coagulation | GO:0050817 | 78 | 0.026 | |
| mesenchyme development | GO:0060485 | 152 | 0.026 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.026 | |
| syncytiotrophoblast cell differentiation involved in labyrinthine layer development | GO:0060715 | 2 | 0.026 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.026 | |
| regulation of cell migration involved in sprouting angiogenesis | GO:0090049 | 4 | 0.026 | |
| carbon catabolite regulation of transcription | GO:0045990 | 4 | 0.026 | |
| mapk cascade | GO:0000165 | 281 | 0.026 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.026 | |
| female somatic sex determination | GO:0019101 | 1 | 0.025 | |
| synapse organization | GO:0050808 | 125 | 0.025 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.025 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.025 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.025 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.025 | |
| angiogenesis | GO:0001525 | 201 | 0.025 | |
| female gonad development | GO:0008585 | 71 | 0.025 | |
| blood coagulation | GO:0007596 | 76 | 0.025 | |
| carbon catabolite regulation of transcription from rna polymerase ii promoter | GO:0000429 | 4 | 0.025 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.025 | |
| interleukin 8 production | GO:0032637 | 4 | 0.025 | |
| digestive tract development | GO:0048565 | 190 | 0.025 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.025 | |
| ectoderm formation | GO:0001705 | 3 | 0.025 | |
| nephrogenic mesenchyme development | GO:0072076 | 3 | 0.025 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.025 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.025 | |
| regulation of stress activated mapk cascade | GO:0032872 | 69 | 0.024 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.024 | |
| cell recognition | GO:0008037 | 83 | 0.024 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.024 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.024 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.024 | |
| retinal blood vessel morphogenesis | GO:0061304 | 3 | 0.024 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.024 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.024 | |
| testosterone biosynthetic process | GO:0061370 | 2 | 0.024 | |
| positive regulation of interleukin 8 secretion | GO:2000484 | 1 | 0.024 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.024 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.024 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.024 | |
| immune effector process | GO:0002252 | 321 | 0.024 | |
| regulation of protein localization | GO:0032880 | 231 | 0.024 | |
| planar cell polarity pathway involved in pericardium morphogenesis | GO:0061354 | 2 | 0.024 | |
| cell maturation | GO:0048469 | 127 | 0.024 | |
| response to growth factor | GO:0070848 | 198 | 0.024 | |
| cation transport | GO:0006812 | 399 | 0.024 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.023 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.023 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.023 | |
| response to retinoic acid | GO:0032526 | 56 | 0.023 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.023 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.023 | |
| specification of loop of henle identity | GO:0072086 | 4 | 0.023 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.023 | |
| telencephalon development | GO:0021537 | 186 | 0.023 | |
| maintenance of cell number | GO:0098727 | 3 | 0.023 | |
| pattern specification involved in metanephros development | GO:0072268 | 4 | 0.023 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.023 | |
| sympathetic nervous system development | GO:0048485 | 22 | 0.023 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.023 | |
| gtp metabolic process | GO:0046039 | 144 | 0.023 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.023 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.023 | |
| planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:0061350 | 2 | 0.023 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.023 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.023 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.023 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.023 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.023 | |
| membrane organization | GO:0061024 | 245 | 0.023 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.023 | |
| prostate gland development | GO:0030850 | 48 | 0.022 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.022 | |
| metanephric nephron development | GO:0072210 | 34 | 0.022 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.022 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.022 | |
| negative regulation of transcription from rna polymerase ii promoter by glucose | GO:0000433 | 1 | 0.022 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.022 | |
| regulation of apoptotic process involved in outflow tract morphogenesis | GO:1902256 | 2 | 0.022 | |
| hormone secretion | GO:0046879 | 128 | 0.022 | |
| muscle cell development | GO:0055001 | 133 | 0.022 | |
| regulation of insulin secretion involved in cellular response to glucose stimulus | GO:0061178 | 31 | 0.022 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.022 | |
| planar cell polarity pathway involved in heart morphogenesis | GO:0061346 | 3 | 0.022 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.022 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.022 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.022 | |
| cerebellum vasculature development | GO:0061300 | 1 | 0.022 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.022 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.021 | |
| sensory perception of sound | GO:0007605 | 97 | 0.021 | |
| cardiac septum development | GO:0003279 | 59 | 0.021 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.021 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.021 | |
| gastrulation | GO:0007369 | 116 | 0.021 | |
| regulation of glucose metabolic process | GO:0010906 | 60 | 0.021 | |
| endocrine system development | GO:0035270 | 98 | 0.021 | |
| negative regulation of mitotic cell cycle embryonic | GO:0045976 | 2 | 0.021 | |
| peptide secretion | GO:0002790 | 114 | 0.021 | |
| central nervous system neuron development | GO:0021954 | 67 | 0.021 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.021 | |
| gliogenesis | GO:0042063 | 141 | 0.021 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.021 | |
| endocardial cushion to mesenchymal transition involved in heart valve formation | GO:0003199 | 4 | 0.021 | |
| cardiac septum morphogenesis | GO:0060411 | 46 | 0.021 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.021 | |
| regulation of jnk cascade | GO:0046328 | 62 | 0.021 | |
| regulation of cell cell adhesion mediated by cadherin | GO:2000047 | 2 | 0.021 | |
| chromatin modification | GO:0016568 | 187 | 0.021 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.021 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.021 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.021 | |
| maternal determination of anterior posterior axis embryo | GO:0008358 | 2 | 0.021 | |
| cellular response to lipid | GO:0071396 | 145 | 0.021 | |
| regulation of epithelial to mesenchymal transition | GO:0010717 | 22 | 0.021 | |
| urogenital system development | GO:0001655 | 261 | 0.021 | |
| septum primum development | GO:0003284 | 4 | 0.021 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.020 | |
| jnk cascade | GO:0007254 | 72 | 0.020 | |
| striated muscle cell development | GO:0055002 | 125 | 0.020 | |
| mitral valve morphogenesis | GO:0003183 | 4 | 0.020 | |
| negative regulation of alcohol biosynthetic process | GO:1902931 | 4 | 0.020 | |
| developmental cell growth | GO:0048588 | 84 | 0.020 | |
| actin mediated cell contraction | GO:0070252 | 15 | 0.020 | |
| neuronal action potential | GO:0019228 | 54 | 0.020 | |
| intracellular protein transport | GO:0006886 | 204 | 0.020 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.020 | |
| cilium morphogenesis | GO:0060271 | 102 | 0.020 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.020 | |
| regulation of ketone biosynthetic process | GO:0010566 | 2 | 0.020 | |
| cation homeostasis | GO:0055080 | 212 | 0.020 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.020 | |
| vascular endothelial growth factor receptor signaling pathway | GO:0048010 | 24 | 0.020 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.020 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.020 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.020 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.020 | |
| wnt signaling pathway involved in forebrain neuroblast division | GO:0021874 | 2 | 0.020 | |
| response to peptide | GO:1901652 | 136 | 0.020 | |
| neural crest cell development | GO:0014032 | 48 | 0.020 | |
| dephosphorylation | GO:0016311 | 129 | 0.020 | |
| forebrain neuron development | GO:0021884 | 30 | 0.020 | |
| tissue remodeling | GO:0048771 | 102 | 0.020 | |
| nuclear transport | GO:0051169 | 139 | 0.020 | |
| tissue homeostasis | GO:0001894 | 115 | 0.020 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.020 | |
| autonomic nervous system development | GO:0048483 | 43 | 0.020 | |
| inflammatory response | GO:0006954 | 244 | 0.020 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.020 | |
| embryonic axis specification | GO:0000578 | 30 | 0.020 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.020 | |
| organelle assembly | GO:0070925 | 177 | 0.020 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.020 | |
| carbon catabolite activation of transcription from rna polymerase ii promoter | GO:0000436 | 4 | 0.020 | |
| ephrin receptor signaling pathway | GO:0048013 | 20 | 0.020 | |
| neuroblast proliferation | GO:0007405 | 49 | 0.020 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.020 | |
| planar cell polarity pathway involved in outflow tract morphogenesis | GO:0061347 | 2 | 0.019 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.019 | |
| endodermal cell fate determination | GO:0007493 | 2 | 0.019 | |
| response to nutrient levels | GO:0031667 | 109 | 0.019 | |
| metanephric capsule morphogenesis | GO:0072265 | 1 | 0.019 | |
| cardiac chamber development | GO:0003205 | 108 | 0.019 | |
| adaptive immune response | GO:0002250 | 155 | 0.019 | |
| cerebral cortex radial glia guided migration | GO:0021801 | 17 | 0.019 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.019 | |
| heart process | GO:0003015 | 94 | 0.019 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.019 | |
| mesodermal cell migration | GO:0008078 | 4 | 0.019 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.019 | |
| positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090100 | 43 | 0.019 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.019 | |
| neural tube formation | GO:0001841 | 108 | 0.019 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.019 | |
| neuromuscular process controlling balance | GO:0050885 | 59 | 0.019 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.019 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.019 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.019 | |
| mitral valve development | GO:0003174 | 4 | 0.019 | |
| cell fate specification | GO:0001708 | 72 | 0.019 | |
| cofactor transport | GO:0051181 | 4 | 0.019 | |
| mesangial cell development | GO:0072143 | 4 | 0.019 | |
| lung epithelium development | GO:0060428 | 37 | 0.019 | |
